| __timestamp | Geron Corporation | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 20707000 | 12122000 |
| Thursday, January 1, 2015 | 17831000 | 13380000 |
| Friday, January 1, 2016 | 18047000 | 21221000 |
| Sunday, January 1, 2017 | 11033000 | 26887000 |
| Monday, January 1, 2018 | 13432000 | 27863000 |
| Tuesday, January 1, 2019 | 52072000 | 55908000 |
| Wednesday, January 1, 2020 | 51488000 | 59392000 |
| Friday, January 1, 2021 | 85727000 | 69012000 |
| Saturday, January 1, 2022 | 95518000 | 36082000 |
| Sunday, January 1, 2023 | 125046000 | 24537000 |
In the ever-evolving pharmaceutical industry, research and development (R&D) is the lifeblood of innovation. Over the past decade, Ligand Pharmaceuticals and Geron Corporation have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Geron Corporation's R&D expenses surged by over 500%, peaking in 2023 with a 150% increase compared to 2022. This aggressive investment reflects Geron's commitment to pioneering advancements in oncology.
Conversely, Ligand Pharmaceuticals exhibited a more conservative approach, with R&D spending peaking in 2021 before declining by nearly 65% by 2023. This shift may indicate a strategic pivot towards optimizing existing assets or exploring alternative growth avenues. As these companies navigate the competitive landscape, their R&D trajectories offer valuable insights into their future directions and potential breakthroughs.
Who Prioritizes Innovation? R&D Spending Compared for AbbVie Inc. and Geron Corporation
Research and Development Expenses Breakdown: Novartis AG vs Geron Corporation
Zoetis Inc. or Geron Corporation: Who Invests More in Innovation?
GSK plc vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Alnylam Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and Ligand Pharmaceuticals Incorporated
United Therapeutics Corporation or Ligand Pharmaceuticals Incorporated: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Ligand Pharmaceuticals Incorporated
Apellis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Who Generates More Revenue? Ligand Pharmaceuticals Incorporated or Geron Corporation
R&D Spending Showdown: Mesoblast Limited vs Geron Corporation
Research and Development Investment: Geron Corporation vs BioCryst Pharmaceuticals, Inc.